Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christiana M. Brenin"'
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
This paper describes the design of an early phase, prospective trial evaluating the safety and tolerability of the combination of the histone deacetylase inhibitor, entinostat, in combination with capecitabine. The study consists of two parts; an ini
Externí odkaz:
https://doaj.org/article/7b52e577d8b54c3eac00e3aecd6fe05f
Autor:
Patrick M. Dillon, Gina R. Petroni, Mark E. Smolkin, David R. Brenin, Kimberly A. Chianese-Bullock, Kelly T. Smith, Walter C. Olson, Ibrahim S. Fanous, Carmel J. Nail, Christiana M. Brenin, Emily H. Hall, Craig L. Slingluff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-10 (2017)
Abstract Background Breast cancer remains a leading cause of cancer death worldwide. There is evidence that immunotherapy may play a role in the eradication of residual disease. Peptide vaccines for immunotherapy are capable of durable immune memory,
Externí odkaz:
https://doaj.org/article/6b7cf945a9c4403e807ea3f6e96728ea
Autor:
Christiana M. Brenin, Anne M. Mills, Chelsea E. Gottlieb, Scott M. Wendroth, Kristen A. Atkins
Publikováno v:
American Journal of Surgical Pathology. 40:1109-1116
Apocrine carcinomas comprise ∼1% of all breast cancers and are characterized by large cells bearing abundant eosinophilic granular cytoplasm, round nuclei, and prominent nucleoli. They are typically estrogen receptor/progesterone receptor/HER2 nega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e634deb845548e71e18a58b25167121
https://doi.org/10.1097/pas.0000000000000671
https://doi.org/10.1097/pas.0000000000000671
Autor:
Kristi Ellen, Geoffrey R. Weiss, Patrick G. Northup, Petra Jones, Reid B. Adams, Penny Bashlor, Tyvin A. Rich, Carl L. Berg, Michel Kahaleh, Vanessa M. Shami, Rajnish Mishra, Paul Yeaton, Christiana M. Brenin, Barbara E. Kurth
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 6(3)
Photodynamic therapy (PDT) for unresectable cholangiocarcinoma is associated with improvement in cholestasis, quality of life, and potentially survival. We compared survival in patients with unresectable cholangiocarcinoma undergoing endoscopic retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0011715e97fca6d8c938ffad984c1171
https://pubmed.ncbi.nlm.nih.gov/18328433
https://pubmed.ncbi.nlm.nih.gov/18328433
Autor:
Carl L. Berg, Barbara E. Kurth, Geoffrey R. Weiss, Patrick G. Northup, Michel Kahaleh, Kristi Ellen, Vanessa M. Shami, Tyvin A. Rich, Penny Bashlor, Reid B. Adams, Rajnish Mishra, Christiana M. Brenin, Paul Yeaton
Publikováno v:
Gastrointestinal Endoscopy. 65:AB96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1f713b3e379bd0dc1123e9e66ac9264
https://doi.org/10.1016/j.gie.2007.03.106
https://doi.org/10.1016/j.gie.2007.03.106